Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Escitalopram and Amygdalar Activation in Depression based on Serotonin Transporter Genetics
NCT00456430Phase 4Completed
- Sponsor
- Indiana University School of Medicine
- Start
- Jul 2003
- Primary completion
- Aug 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Escitalopram oxalate oral solution in major depressive disorder (MDD), sponsored by Indiana University School of Medicine. Started Jul 2003; status: completed.
02
Drugs
Escitalopram oxalate oral solution
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00456430.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00456430.